HER2-Low Expression in Breast Cancer: Opportunities for Expanding Treatment Benefit to More Patients
1:25:22
A New View of the Spectrum of HER2 Expression and Significance of HER2 Low in Breast Cancer
57:18
Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast Cancer
1:01:53
Report Back from SABCS 2021: What’s the Latest in Metastatic Breast Cancer Research?
54:43
The Science of HER2-low Breast Cancer and Implications for the Pathology Team
5:05
Anti-HER2 Mechanisms of Approved HER2 Inhibitors
54:22
The Link Between Nutrition and Cancer
49:04
Advancing Therapeutic Control in Desmoid Tumors
1:51:20